• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[糖尿病的晚期并发症——免疫反应的后果?]

[Late complications of diabetes mellitus-consequence of immunologic reactions?].

作者信息

Bemm H, Lohmann D

出版信息

Allerg Immunol (Leipz). 1974;20-21(1):15-20.

PMID:4282823
Abstract

164 patients, who required clinical treatment because of newly diagnosed diabetes mellitus or known and metabolically disordered diabetes mellitus, were examined for insulin antibody activities. The results of antibody determinations in serum are compared with late diabetic complications. The time of treatment with insulin and the duration of diabetes were found to be closely correlated with the development of organic complications and insulin antibodies. The symptoms of the late diabetic syndrome are considered to be consequences of an immunological process. Due to the variability of the development of insulin antibodies and late diabetic complications the individual immunological manner of reaction of the organism different antibody properties, and nonspecific immunological processes may be of decisive importance to the clinical development.

摘要

164例因新诊断的糖尿病或已知的代谢紊乱性糖尿病而需要临床治疗的患者接受了胰岛素抗体活性检测。将血清中抗体测定结果与糖尿病晚期并发症进行比较。发现胰岛素治疗时间和糖尿病病程与器质性并发症及胰岛素抗体的发生密切相关。糖尿病晚期综合征的症状被认为是免疫过程的结果。由于胰岛素抗体和糖尿病晚期并发症发展的变异性,机体不同抗体特性的个体免疫反应方式以及非特异性免疫过程可能对临床发展起决定性作用。

相似文献

1
[Late complications of diabetes mellitus-consequence of immunologic reactions?].[糖尿病的晚期并发症——免疫反应的后果?]
Allerg Immunol (Leipz). 1974;20-21(1):15-20.
2
[Anti-insulin antibodies and circulating immune complexes in patients with diabetes mellitus].糖尿病患者中的抗胰岛素抗体与循环免疫复合物
Ter Arkh. 1987;59(11):15-8.
3
Insulin antibodies in diabetics receiving a single type of insulin.接受单一类型胰岛素治疗的糖尿病患者体内的胰岛素抗体。
Med Interne. 1982 Jan-Mar;20(1):9-13.
4
Insulin antibodies and the control of diabetes.胰岛素抗体与糖尿病的控制
Q J Med. 1975 Oct;44(176):543-53.
5
[Serum C4 concentration, diabetes mellitus and diabetic microangiopathy].
Med Clin (Barc). 1988 Dec 3;91(19):728-31.
6
[Pathogenesis of diabetic microangiopathy. Fluoroangioretinal observations during monocomponent insulin therapy].
Ann Osp Maria Vittoria Torino. 1978 Jan-Jun;21(1-6):47-68.
7
[Long-term clinical results with monocomponent insulin (MC lente) in infantile and juvenile diabetes].[单组分胰岛素(MC 中效胰岛素)治疗婴幼儿及青少年糖尿病的长期临床结果]
Ann Osp Maria Vittoria Torino. 1976 Jan-Jun;19(16):7-26.
8
[The study of insulin antibodies in different forms of diabetes mellitus].[不同类型糖尿病中胰岛素抗体的研究]
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1979 Sep-Oct;31(5):421-8.
9
[Antibodies to insulin in patients with diabetes mellitus].[糖尿病患者体内的胰岛素抗体]
Vrach Delo. 1973 Feb;2:110-2.
10
Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients.糖尿病患者循环嗜碱性粒细胞对外源性胰岛素的免疫致敏作用。
Panminerva Med. 1981 Apr-Jun;23(2):81-8.